# A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis

> **NCT00683969** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 136 (estimated)

## Conditions studied

- Myasthenia Gravis, Generalized

## Interventions

- **DRUG:** mycophenolate mofetil (CellCept)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00683969
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2008-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683969, "A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00683969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*